CG Oncology (CGON) Amortizatization of Intangibles (2023 - 2025)

CG Oncology filings provide 3 years of Amortizatization of Intangibles readings, the most recent being -$951000.0 for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles rose 24.22% to -$951000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 million, a 79.69% decrease, with the full-year FY2025 number at $1.0 million, down 79.69% from a year prior.
  • Amortizatization of Intangibles hit -$951000.0 in Q4 2025 for CG Oncology, down from -$201000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.5 million in Q2 2024 to a low of -$1.3 million in Q4 2024.
  • Median Amortizatization of Intangibles over the past 3 years was $1.3 million (2023), compared with a mean of $862400.0.
  • The widest YoY moves for Amortizatization of Intangibles: up 37.33% in 2024, down 185.61% in 2024.
  • CG Oncology's Amortizatization of Intangibles stood at $1.5 million in 2023, then tumbled by 185.61% to -$1.3 million in 2024, then increased by 24.22% to -$951000.0 in 2025.
  • The last three reported values for Amortizatization of Intangibles were -$951000.0 (Q4 2025), -$201000.0 (Q3 2025), and $1.9 million (Q2 2025) per Business Quant data.